|
Hypertension
Citations 1-10 of 46 total displayed.
|
Most recent content
(1 Aug 2007):
|
- Therapeutics
Review: drugs for mild to moderate hypertension in pregnancy reduce the risk of severe hypertension but not pre-eclampsia
- Laura A Magee
Evid Based Med 2007; 12: 116.
[Extract]
[Full text]
[ web only table ]
|
Past content
(since Jan 2000):
|
- Therapeutics
Review: ß blockers differ in their efficacy for preventing major cardiovascular events in younger and older patients
- Robert Weiss
Evid Based Med 2006; 11: 168.
[Extract]
[Full text]
- Therapeutics
Review: the renoprotective effects of ACE inhibitors and ARBs independent of blood pressure control are uncertain
- Catherine Clase and Amit X Garg
Evid Based Med 2006; 11: 145.
[Extract]
[Full text]
- Therapeutics
Review: ß blockers are less effective than other antihypertensive drugs for reducing risk of stroke in primary hypertension
- Peter Rudd
Evid Based Med 2006; 11: 85.
[Extract]
[Full text]
- Quality improvement
Review: care assisted by nurses or pharmacists provides better blood pressure control
- David Gutknecht
Evid Based Med 2006; 11: 92.
[Extract]
[Full text]
- Therapeutics
Amlodipine plus perindopril was better than atenolol plus bendroflumethiazide for reducing complications in hypertension
- Kelly B Zarnke
Evid Based Med 2006; 11: 42.
[Extract]
[Full text]
- Therapeutics
Review: angiotensin converting enzyme inhibitors and angiotensin receptor blockers prevent atrial fibrillation
- V J Karthikeyan and Gregory Y H Lip
Evid Based Med 2006; 11: 15.
[Extract]
[Full text]
- Therapeutics
Amlodipine or lisinopril was not better than chlorthalidone for reducing CVD risk in hypertensive black or non-black patients
- Mark Rosenberg and Meera Jain
Evid Based Med 2005; 10: 170.
[Extract]
[Full text]
[ Web-only table ]
- Therapeutics
Intensified blood pressure (BP) control was not better than conventional BP control in non-diabetic chronic renal disease
- Bruce Culleton
Evid Based Med 2005; 10: 138.
[Extract]
[Full text]
- Therapeutics
Review: atenolol may be ineffective for reducing cardiovascular morbidity or all cause mortality in hypertension
- J Kennedy Cruickshank
Evid Based Med 2005; 10: 74.
[Extract]
[Full text]
|
|
